Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Regulatory Toxicology and Pharmacology : RTP|October 23, 2012
Repeated dose (14 days) rat intramuscular toxicology study of Her1 vaccineA Mancebo, A Casacó, B Sánchez, et al.
Genes, Chromosomes & Cancer|September 4, 2010
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case familiesRosemary L Balleine, Pamela J Provan, Gulietta M Pupo, et al.
Breast Cancer Research : BCR|November 11, 2005
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancerAaron G Lewis, James Flanagan, Anna Marsh, et al.
Breast Cancer Research and Treatment|December 26, 2006
Mutation analysis of five candidate genes in familial breast cancerAnna Marsh, Sue Healey, Aaron Lewis, et al.
Breast Cancer Research : BCR|October 13, 2001
The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in AustraliaA Marsh, A B Spurdle, B C Turner, et al.
Molecular Oncology|January 31, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanomaMatteo S Carlino, Jason R Todd, Kavitha Gowrishankar, et al.
Familial Cancer|October 9, 2007
Is MSH2 a breast cancer susceptibility gene?Ee Ming Wong, Andrea A Tesoriero, Gulietta M Pupo, et al.
Oncogene|March 5, 2013
Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factorT M Becker, S C Boyd, B Mijatov, et al.
Regulatory Toxicology and Pharmacology : RTP|October 16, 2010
Acute oral, pulmonary and intravenous toxicity/pathogenicity testing of a new formulation of Bacillus thuringiensis var israelensis SH-14 in ratsA Mancebo, T Molier, B González, et al.
Pageof 7